Salvia Investment GmbH

Filings at 1 company/10% owner · Bambusa Therapeutics, Inc.

All 5 shown

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Bambusa Therapeutics, Inc. 10% owner
160,860 sharesConversion
TradedNov 2, 2026FiledNov 2, 2026
Bambusa Therapeutics, Inc. 10% owner
1,473,775 sharesConversion
TradedNov 2, 2026FiledNov 2, 2026
Bambusa Therapeutics, Inc. 10% owner
3,135,066 sharesConversion
TradedNov 2, 2026FiledNov 2, 2026
Bambusa Therapeutics, Inc. 10% owner
$6,000,000Open-market buy
TradedNov 2, 2026FiledNov 2, 2026
Bambusa Therapeutics, Inc. 10% owner
—Conversion
TradedNov 2, 2026FiledNov 2, 2026